Jubilant Pharmova announced second quarter results: profit increased by 64.48% year-on-year

Jubilant Pharmova announced second quarter results: profit increased by 64.48% year-on-year

2024-10-26 10:13:16 :

Jubilant Pharmova Second Quarter Results Live: Jubilant Pharmova reported second quarter results on October 25, 2024, showing significant growth in profitability. The company’s revenue increased by 4.28% year-on-year, and its profit increased by 64.48% year-on-year. Although the year-on-year performance was good, it declined slightly compared with the previous quarter, with revenue growing only 1.19% and profit falling sharply by 78.68%.

In terms of expenses, selling, general and administrative expenses increased by 2.06% month-on-month and 6.11% year-on-year. The increase in expenses may lead to a decrease in operating income, which fell 66.98% from the previous quarter despite a year-on-year increase of 26.58%.

Second quarter earnings per share (EPS) reported at $7.09, an impressive 80.04% increase compared to the same period last year. Investors may find this number encouraging, as it indicates steady growth in earnings per share.

Jubilant Pharmova faced a slight decline over the past week, returning -5.57%. However, the company has shown significant recovery over the longer term, returning 63.48% over the past six months and an impressive 103.14% year-to-date. This performance brought the market capitalization to $17,551.15 Cr, 52-week high $1247.15 and lowest price $318.75.

Looking ahead, analyst sentiment remains positive. Of the three analysts covering the company as of October 26, 2024, one has a Buy rating and two have a Strong Buy rating. The consensus recommendation was a “Strong Buy,” indicating confidence in the company’s future performance.

Thriving pharmaceutical company finances

periodQ2Q1month-on-month growthQ2year-on-year growth
total revenue1752.31731.7+1.19%1680.3+4.28%
Total Selling/General/Administrative Expenses564.3552.9+2.06%531.8+6.11%
Depreciation/Amortization91.490.7+0.77%96.6-5.38%
total operating expenses1568.5Chapter 1175+33.49%1535.1+2.18%
operating income183.8556.7-66.98%145.2+26.58%
net income before tax144.4499.7-71.1%98+47.35%
net income102.8482.1-78.68%62.5+64.48%
Diluted normalized earnings per share7.096.34+11.92%3.94+80.04%
Get the latest updates on quarterly results with our results calendar

Follow us On Social Media   Twitter/X

Join WhatsApp

Join Now

---Advertisement---